首页 > 最新文献

American journal of clinical and experimental immunology最新文献

英文 中文
Ultrashort plasma cell-free DNA: a novel non-invasive marker for cancer diagnostics. 超短等离子体无细胞 DNA:癌症诊断的新型无创标记物。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/UQTM2281
Guodong Zhao

Recent studies have shown that ultrashort plasma cell-free DNA (uscfDNA), a novel type of cfDNA fragment approximately 50 nucleotides long, differs from conventional monocyte-derived cfDNA in several aspects, including specific extraction requirements and a higher incidence of tumor-specific genetic alterations. uscfDNA shows promise in enhancing liquid biopsy sensitivity for cancer detection, with distinct methylation profiles observed in cancer patients. These findings suggest uscfDNA analysis could significantly improve non-invasive cancer diagnostics, offering new avenues for early detection and personalized medicine strategies.

最近的研究表明,超短无血浆细胞DNA(uscfDNA)是一种新型的cfDNA片段,长约50个核苷酸,它与传统的单核细胞衍生cfDNA有多方面的不同,包括特定的提取要求和更高的肿瘤特异性基因改变发生率。这些研究结果表明,uscfDNA 分析可显著改善非侵入性癌症诊断,为早期检测和个性化医疗策略提供新途径。
{"title":"Ultrashort plasma cell-free DNA: a novel non-invasive marker for cancer diagnostics.","authors":"Guodong Zhao","doi":"10.62347/UQTM2281","DOIUrl":"10.62347/UQTM2281","url":null,"abstract":"<p><p>Recent studies have shown that ultrashort plasma cell-free DNA (uscfDNA), a novel type of cfDNA fragment approximately 50 nucleotides long, differs from conventional monocyte-derived cfDNA in several aspects, including specific extraction requirements and a higher incidence of tumor-specific genetic alterations. uscfDNA shows promise in enhancing liquid biopsy sensitivity for cancer detection, with distinct methylation profiles observed in cancer patients. These findings suggest uscfDNA analysis could significantly improve non-invasive cancer diagnostics, offering new avenues for early detection and personalized medicine strategies.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 4","pages":"202-203"},"PeriodicalIF":1.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411157/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advance in the mechanism and clinical research of myalgia in long COVID. 长COVID肌痛的机制和临床研究进展。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/TXVO6284
Xiuyun Zhai, Weijun Wu, Siliang Zeng, Yun Miao

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, mortality rates of coronavirus disease 2019 (COVID-19) have significantly decreased. However, a variable proportion of patients exhibit persistent prolonged symptoms of COVID-19 infection (long COVID). This virus primarily attacks respiratory system, but numerous individuals complain persistent skeletal muscle pain or worsening pre-existing muscle pain post COVID-19, which severely affects the quality of life and recovery. Currently, there is limited research on the skeletal muscle pain in long COVID. In this brief review, we review potential pathological mechanisms of skeletal muscle pain in long COVID, and summarize the various auxiliary examinations and treatments for skeletal muscle pain in long COVID. We consider abnormal activation of inflammatory response, myopathy, and neurological damages as pivotal pathological mechanisms of skeletal muscle pain in long COVID. A comprehensive examination is significantly important in order to work out effective treatment plans and relieve skeletal muscle pain. So far, rehabilitation interventions for myalgia in long COVID contain but are not limited to drug, nutraceutical therapy, gut microbiome-targeted therapy, interventional therapy and strength training. Our study provides a potential mechanism reference for clinical researches, highlighting the importance of comprehensive approach and management of skeletal muscle pain in long COVID. The relief of skeletal muscle pain will accelerate rehabilitation process, improve activities of daily living and enhance the quality of life, promoting individuals return to society with profound significance.

随着严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的不断发展,冠状病毒病 2019(COVID-19)的死亡率已显著下降。然而,仍有不同比例的患者表现出持续时间较长的 COVID-19 感染症状(长 COVID)。这种病毒主要侵袭呼吸系统,但许多人在感染COVID-19后会出现持续性骨骼肌疼痛或原有肌肉疼痛加重,严重影响生活质量和康复。目前,有关长效 COVID 引起的骨骼肌疼痛的研究十分有限。在这篇简短的综述中,我们回顾了长 COVID 骨骼肌疼痛的潜在病理机制,并总结了长 COVID 骨骼肌疼痛的各种辅助检查和治疗方法。我们认为炎症反应异常激活、肌病和神经损伤是长程COVID骨骼肌疼痛的关键病理机制。全面的检查对于制定有效的治疗方案和缓解骨骼肌疼痛非常重要。迄今为止,针对长COVID肌痛的康复干预措施包括但不限于药物、营养治疗、肠道微生物靶向治疗、介入治疗和力量训练。我们的研究为临床研究提供了潜在的机制参考,强调了综合方法和管理长程COVID骨骼肌疼痛的重要性。骨骼肌疼痛的缓解将加速康复进程,改善日常生活活动,提高生活质量,对促进个体回归社会具有深远意义。
{"title":"Advance in the mechanism and clinical research of myalgia in long COVID.","authors":"Xiuyun Zhai, Weijun Wu, Siliang Zeng, Yun Miao","doi":"10.62347/TXVO6284","DOIUrl":"10.62347/TXVO6284","url":null,"abstract":"<p><p>As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, mortality rates of coronavirus disease 2019 (COVID-19) have significantly decreased. However, a variable proportion of patients exhibit persistent prolonged symptoms of COVID-19 infection (long COVID). This virus primarily attacks respiratory system, but numerous individuals complain persistent skeletal muscle pain or worsening pre-existing muscle pain post COVID-19, which severely affects the quality of life and recovery. Currently, there is limited research on the skeletal muscle pain in long COVID. In this brief review, we review potential pathological mechanisms of skeletal muscle pain in long COVID, and summarize the various auxiliary examinations and treatments for skeletal muscle pain in long COVID. We consider abnormal activation of inflammatory response, myopathy, and neurological damages as pivotal pathological mechanisms of skeletal muscle pain in long COVID. A comprehensive examination is significantly important in order to work out effective treatment plans and relieve skeletal muscle pain. So far, rehabilitation interventions for myalgia in long COVID contain but are not limited to drug, nutraceutical therapy, gut microbiome-targeted therapy, interventional therapy and strength training. Our study provides a potential mechanism reference for clinical researches, highlighting the importance of comprehensive approach and management of skeletal muscle pain in long COVID. The relief of skeletal muscle pain will accelerate rehabilitation process, improve activities of daily living and enhance the quality of life, promoting individuals return to society with profound significance.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 4","pages":"142-164"},"PeriodicalIF":1.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between metabolites and gout: a Mendelian randomization study. 代谢物与痛风之间的关系:孟德尔随机研究。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/UTEW4812
Zhixiang Ding, Liting Wu, Ting Xu, Cui Zhang, Yi Liang, Jia Li, Wenfang Zhuang

Background: Gout is closely tied to metabolism, yet there is limited evidence on how metabolites may cause or prevent the condition.

Methods: This study utilized a two-sample Mendelian randomization (MR) analysis to evaluate the causal relationship between 1,400 serum metabolites and gout. We primarily employed the inverse variance-weighted (IVW) method to estimate causal effects, supplemented by MR-Egger regression, weighted median, simple mode, and weighted mode for comprehensive evaluations. Additionally, we conducted tests for pleiotropy and heterogeneity.

Results: After a rigorous selection process, we identified eight known metabolites and four unknown metabolites associated with gout. Among the eight known metabolites, Glucuronide of piperine metabolite C17H21NO3 and the Phosphate to mannose ratio were positively associated with an increased risk of gout. Conversely, levels of 5 alpha-androstan-3 beta, 17 alpha-diol disulfate, Pantoate, N-carbamoylalanine, Sphingomyelin (d18:0/20:0, d16:0/22:0), Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), and Mannose were linked to a decreased risk of gout.

Conclusion: This study identified eight metabolites from 1,400 blood samples significantly linked to gout risk. Integrating genomics and metabolomics offers valuable insights for gout screening and prevention, indicating that specific blood metabolites can help identify individuals at higher risk.

背景:痛风与新陈代谢密切相关:痛风与新陈代谢密切相关,但关于代谢物如何导致或预防痛风的证据却很有限:本研究采用双样本孟德尔随机分析法(MR)评估了 1400 种血清代谢物与痛风之间的因果关系。我们主要采用反方差加权法(IVW)来估计因果效应,并辅以MR-Egger回归法、加权中位数法、简单模式法和加权模式法进行综合评估。此外,我们还对多义性和异质性进行了检验:经过严格筛选,我们确定了与痛风相关的 8 种已知代谢物和 4 种未知代谢物。在这8种已知代谢物中,胡椒碱代谢物C17H21NO3的葡萄糖醛酸苷和磷酸与甘露糖的比率与痛风风险的增加呈正相关。相反,5 α-雄甾烷-3 β、17 α-二醇二硫酸盐、泛酸、N-氨基甲酰丙氨酸、鞘磷脂(d18:0/20:0、d16:0/22:0)、羟基棕榈酰鞘磷脂(d18:1/16:0(OH))和甘露糖的水平与痛风风险的降低有关:这项研究从1,400份血液样本中发现了与痛风风险密切相关的8种代谢物。基因组学和代谢组学的结合为痛风的筛查和预防提供了宝贵的见解,表明特定的血液代谢物有助于识别高风险人群。
{"title":"The relationship between metabolites and gout: a Mendelian randomization study.","authors":"Zhixiang Ding, Liting Wu, Ting Xu, Cui Zhang, Yi Liang, Jia Li, Wenfang Zhuang","doi":"10.62347/UTEW4812","DOIUrl":"10.62347/UTEW4812","url":null,"abstract":"<p><strong>Background: </strong>Gout is closely tied to metabolism, yet there is limited evidence on how metabolites may cause or prevent the condition.</p><p><strong>Methods: </strong>This study utilized a two-sample Mendelian randomization (MR) analysis to evaluate the causal relationship between 1,400 serum metabolites and gout. We primarily employed the inverse variance-weighted (IVW) method to estimate causal effects, supplemented by MR-Egger regression, weighted median, simple mode, and weighted mode for comprehensive evaluations. Additionally, we conducted tests for pleiotropy and heterogeneity.</p><p><strong>Results: </strong>After a rigorous selection process, we identified eight known metabolites and four unknown metabolites associated with gout. Among the eight known metabolites, Glucuronide of piperine metabolite C17H21NO3 and the Phosphate to mannose ratio were positively associated with an increased risk of gout. Conversely, levels of 5 alpha-androstan-3 beta, 17 alpha-diol disulfate, Pantoate, N-carbamoylalanine, Sphingomyelin (d18:0/20:0, d16:0/22:0), Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), and Mannose were linked to a decreased risk of gout.</p><p><strong>Conclusion: </strong>This study identified eight metabolites from 1,400 blood samples significantly linked to gout risk. Integrating genomics and metabolomics offers valuable insights for gout screening and prevention, indicating that specific blood metabolites can help identify individuals at higher risk.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 4","pages":"177-186"},"PeriodicalIF":1.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers. 从 TCGA 癌症中评估肿瘤抑制因子和癌基因的特征。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-08-25 eCollection Date: 2024-01-01 DOI: 10.62347/XMZW6604
Claire Shen, Richard Geng, Sissi Zhu, Michael Huang, Jeffrey Liang, Binze Li, Yongsheng Bai

Mutations in oncogenes and tumor suppressor genes can significantly impact cellular function during cancer development. A comprehensive analysis of their mutation patterns and significant gene ontology terms can provide insights into cancer emergence and suggest potential targets for drug development. This study analyzes twelve cancer subtypes by focusing on significant genetic and molecular factors. Two common genetic mutations associated with cancer are single nucleotide variants (SNVs) and copy number alterations (CNAs). Oncogenes, derived from mutated proto-oncogenes, disrupt normal cell functions and promote cancer, while tumor suppressor genes, often inactivated by mutations, regulate cell processes like proliferation and DNA damage response. This study analyzed datasets from The Cancer Genome Atlas (TCGA), which provides extensive genomic data across various cancers. In our analysis results, many genes with significant p-values based on Kaplan Meier gene expression data were identified in eight cancers (BRCA, BLCA, HNSC, KIRC, LUAD, KIRP, LUSC, STAD). Moreover, STAD is the only cancer for genes with both significant p-values and functional terms reported. Interestingly, we found that LIHC was the cancer reported with only one CNA mutated gene and its survival plot p-value being significant. Additionally, KICH has no reported significant genes at all. Our study proposed the relationship between tumor suppressor and oncogenes and shed light on cancer tumorigenesis due to genetic mutations.

癌基因和抑癌基因的突变会在癌症发展过程中对细胞功能产生重大影响。对它们的突变模式和重要的基因本体术语进行全面分析,可以深入了解癌症的发生,并提出潜在的药物开发靶点。本研究通过关注重要的遗传和分子因素,对十二种癌症亚型进行了分析。与癌症相关的两种常见基因突变是单核苷酸变异(SNV)和拷贝数改变(CNA)。癌基因由突变的原癌基因衍生而来,会破坏细胞的正常功能并促进癌症的发生,而抑癌基因通常会因突变而失活,它们能调节细胞的增殖和DNA损伤反应等过程。这项研究分析了癌症基因组图谱(TCGA)的数据集,该图谱提供了各种癌症的大量基因组数据。根据我们的分析结果,在八种癌症(BRCA、BLCA、HNSC、KIRC、LUAD、KIRP、LUSC、STAD)中发现了许多基于 Kaplan Meier 基因表达数据的具有显著 p 值的基因。此外,STAD 是唯一一种同时报告了显著 p 值和功能项的癌症。有趣的是,我们发现 LIHC 是仅有一个 CNA 突变基因且其生存图谱 p 值显著的癌症。此外,KICH 没有报告任何有意义的基因。我们的研究提出了抑癌基因和致癌基因之间的关系,并揭示了基因突变导致的癌症肿瘤发生。
{"title":"Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.","authors":"Claire Shen, Richard Geng, Sissi Zhu, Michael Huang, Jeffrey Liang, Binze Li, Yongsheng Bai","doi":"10.62347/XMZW6604","DOIUrl":"10.62347/XMZW6604","url":null,"abstract":"<p><p>Mutations in oncogenes and tumor suppressor genes can significantly impact cellular function during cancer development. A comprehensive analysis of their mutation patterns and significant gene ontology terms can provide insights into cancer emergence and suggest potential targets for drug development. This study analyzes twelve cancer subtypes by focusing on significant genetic and molecular factors. Two common genetic mutations associated with cancer are single nucleotide variants (SNVs) and copy number alterations (CNAs). Oncogenes, derived from mutated proto-oncogenes, disrupt normal cell functions and promote cancer, while tumor suppressor genes, often inactivated by mutations, regulate cell processes like proliferation and DNA damage response. This study analyzed datasets from The Cancer Genome Atlas (TCGA), which provides extensive genomic data across various cancers. In our analysis results, many genes with significant <i>p</i>-values based on Kaplan Meier gene expression data were identified in eight cancers (BRCA, BLCA, HNSC, KIRC, LUAD, KIRP, LUSC, STAD). Moreover, STAD is the only cancer for genes with both significant <i>p</i>-values and functional terms reported. Interestingly, we found that LIHC was the cancer reported with only one CNA mutated gene and its survival plot <i>p</i>-value being significant. Additionally, KICH has no reported significant genes at all. Our study proposed the relationship between tumor suppressor and oncogenes and shed light on cancer tumorigenesis due to genetic mutations.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 4","pages":"187-194"},"PeriodicalIF":1.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the anti-inflammatory effects of whole-body vibration: a meta-analysis based on pre-clinical and clinical evidences. 评估全身振动的抗炎效果:基于临床前和临床证据的荟萃分析。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/LLGY4023
Yiying Wang, Renxin Ji, Bo Yu

Background: Whole-body vibration (WBV) is a commonly used physical exercise for disease prevention and rehabilitation. Recent studies indicated the beneficial mechanism of WBV may be associated with its anti-inflammatory potential, however, its regulatory roles on different inflammatory mediators remained controversial. The aim of this study was to perform a meta-analysis to re-confirm the effects of WBV exercise on various inflammatory factors.

Methods: The PubMed, EMBASE and Cochrane Library databases were searched up to September 2023 to collect all articles comparing WBV with control (or post-pre trials). The effect size was expressed as the standardized mean difference (SMD) and 95% confidence intervals (CI).

Results: A total of 31 eligible studies were included, including 14 pre-clinical and 17 clinical studies. The meta-analysis of pre-clinical studies showed that compared with the control group, WBV exercise could significantly reduce the level of IL-6 (SMD: -1.03, 95% CI: -1.93, -0.13), TNF-α (SMD: -1.36, 95% CI: -2.54, -0.17) (for disease subgroup), IL-1β (SMD: -2.20, 95% CI: -3.24, -1.15), IFN-γ (SMD: -1.91, 95% CI: -2.71, -1.12), IL-4 (SMD: -0.71, 95% CI: -1.39, -0.03) and IL-17 (SMD: -1.32, 95% CI: -2.05, -0.59) overall. Pooling of clinical studies revealed WBV exercise significantly reduced the level of TNF-α (WBV vs control: SMD: -1.11, 95% CI: -2.16, -0.06; post vs pre: SMD: -1.29, 95% CI: -1.91, -0.67), CRP (SMD: -3.59, 95% CI: -6.36, -0.82, P = 0.011) and enhanced the level of IL-10 (WBV vs control: SMD: 2.90, 95% CI: 1.10, 4.71; post vs pre: SMD: 1.75, 95% CI: 0.64, 2.87) and IL-6 (SMD: 0.91, 95% CI: 0.31, 1.52) (healthy subgroup).

Conclusion: WBV may be an effective prevention and rehabilitation tool for inflammatory diseases.

背景:全身振动(WBV)是一种常用的疾病预防和康复体育锻炼方法。最近的研究表明,全身振动的有益机制可能与它的抗炎潜力有关,但它对不同炎症介质的调节作用仍存在争议。本研究旨在进行一项荟萃分析,以重新确认 WBV 运动对各种炎症因子的影响:方法:检索 PubMed、EMBASE 和 Cochrane Library 数据库,收集截至 2023 年 9 月所有比较 WBV 与对照(或后-前试验)的文章。效应大小以标准化平均差异(SMD)和 95% 置信区间(CI)表示:结果:共纳入了 31 项符合条件的研究,包括 14 项临床前研究和 17 项临床研究。临床前研究的荟萃分析表明,与对照组相比,WBV 运动能显著降低 IL-6 (SMD:-1.03,95% CI:-1.93,-0.13)、TNF-α (SMD:-1.36,95% CI:-2.54,-0.17)(疾病亚组)、IL-1β(SMD:-2.20,95% CI:-3.24,-1.15)、IFN-γ(SMD:-1.91,95% CI:-2.71,-1.12)、IL-4(SMD:-0.71,95% CI:-1.39,-0.03)和 IL-17(SMD:-1.32,95% CI:-2.05,-0.59)。对临床研究进行汇总后发现,WBV 运动能显著降低 TNF-α 的水平(WBV 与对照组相比,SMD:-1.11,95% CI:-1.39,-0.03):SMD:-1.11,95% CI:-2.16,-0.06;后与前:SMD:-1.29,95% CI:-1.91,-0.67)、CRP(SMD:-3.59,95% CI:-6.36,-0.82,P = 0.011)的水平,并提高了 IL-10 的水平(WBV 与对照组相比,SMD:2.90,95% CI:-2.05,-0.59):SMD:2.90,95% CI:1.10,4.71;后与前:SMD:1.75,95% CI:0.64,2.87)和 IL-6(SMD:0.91,95% CI:0.31,1.52)(健康亚组):WBV可能是预防和康复炎症性疾病的有效工具。
{"title":"Assessing the anti-inflammatory effects of whole-body vibration: a meta-analysis based on pre-clinical and clinical evidences.","authors":"Yiying Wang, Renxin Ji, Bo Yu","doi":"10.62347/LLGY4023","DOIUrl":"10.62347/LLGY4023","url":null,"abstract":"<p><strong>Background: </strong>Whole-body vibration (WBV) is a commonly used physical exercise for disease prevention and rehabilitation. Recent studies indicated the beneficial mechanism of WBV may be associated with its anti-inflammatory potential, however, its regulatory roles on different inflammatory mediators remained controversial. The aim of this study was to perform a meta-analysis to re-confirm the effects of WBV exercise on various inflammatory factors.</p><p><strong>Methods: </strong>The PubMed, EMBASE and Cochrane Library databases were searched up to September 2023 to collect all articles comparing WBV with control (or post-pre trials). The effect size was expressed as the standardized mean difference (SMD) and 95% confidence intervals (CI).</p><p><strong>Results: </strong>A total of 31 eligible studies were included, including 14 pre-clinical and 17 clinical studies. The meta-analysis of pre-clinical studies showed that compared with the control group, WBV exercise could significantly reduce the level of IL-6 (SMD: -1.03, 95% CI: -1.93, -0.13), TNF-α (SMD: -1.36, 95% CI: -2.54, -0.17) (for disease subgroup), IL-1β (SMD: -2.20, 95% CI: -3.24, -1.15), IFN-γ (SMD: -1.91, 95% CI: -2.71, -1.12), IL-4 (SMD: -0.71, 95% CI: -1.39, -0.03) and IL-17 (SMD: -1.32, 95% CI: -2.05, -0.59) overall. Pooling of clinical studies revealed WBV exercise significantly reduced the level of TNF-α (WBV vs control: SMD: -1.11, 95% CI: -2.16, -0.06; post vs pre: SMD: -1.29, 95% CI: -1.91, -0.67), CRP (SMD: -3.59, 95% CI: -6.36, -0.82, P = 0.011) and enhanced the level of IL-10 (WBV vs control: SMD: 2.90, 95% CI: 1.10, 4.71; post vs pre: SMD: 1.75, 95% CI: 0.64, 2.87) and IL-6 (SMD: 0.91, 95% CI: 0.31, 1.52) (healthy subgroup).</p><p><strong>Conclusion: </strong>WBV may be an effective prevention and rehabilitation tool for inflammatory diseases.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"68-87"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma free cell RNA profiling for the prediction of preeclampsia. 用于预测先兆子痫的血浆游离细胞 RNA 图谱。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/RGRU1280
Yuting Liang
{"title":"Plasma free cell RNA profiling for the prediction of preeclampsia.","authors":"Yuting Liang","doi":"10.62347/RGRU1280","DOIUrl":"10.62347/RGRU1280","url":null,"abstract":"","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"140-141"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China. 中国东部某大学医院与COVID-19感染相关的皮肤表现。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/BDUC7952
Lingyi Lu, Lu Cao, Jing Zhang, Bingjiang Lin

Background: Coronavirus disease 2019 (COVID-19) affects different organ systems, including the skin. A retrospective analysis of skin manifestations in Chinese outpatient and inpatient settings is lacking. The study aims to analyze cutaneous manifestations in COVID-19 patients and the recurrence or aggravation of previous skin diseases.

Materials and methods: A retrospective cross-sectional study was conducted from November 2022 to July 2023 in a university hospital in eastern China. It involved reverse transcriptase polymerase chain reaction (RT-PCR)-positive COVID-19 patients, documenting various skin manifestations and the recurrence or aggravation of pre-existing skin conditions. The pattern of skin lesions and other variables were assessed.

Results: The study included 303 patients, with 127 males and 176 females. Maculopapular rash was the predominant new cutaneous manifestation (54.92%), mainly in middle-aged individuals. Other findings included urticaria (16.39%), herpes zoster (11.89%), and herpes simplex (4.10%), vesicular rashes (2.46%), purpura (2.05%), erythema multiforme (1.64%), livedo reticularis (0.41%) and so on. Severe disease was associated with herpes zoster and livedo reticularis. Critical COVID-19 cases were linked to vesicular rashes, purpura, and erythema multiforme. The mean time for skin lesion emergence post-infection varied from 3 days for seborrheic dermatitis to 17.48 days for herpes zoster. Vasculitic manifestations correlated with elevated D-dimer levels. A total of 59 cases (19.47%) of recurrent or aggravated skin diseases were reported following infection with COVID-19, with dermatitis being the most common, followed by acne and folliculitis, psoriasis, urticaria, bullous pemphigoid, pemphigus, tinea corporis and androgenetic alopecia.

Conclusion: The cutaneous phenotypes delineated in this study expand the dermatologic spectrum associated with COVID-19. Cutaneous manifestations may result from overactive immune responses, complement activation, and microvascular damage. Herpes zoster typically occurs in elderly COVID-19 patients with weaker immune systems or more severe diseases. Purpura and livedo reticularis, although rare, may indicate disease severity. It is possible to predict the course of COVID-19 with different severity through cutaneous manifestations. Recognizing these skin manifestations could aid in predicting COVID-19 severity and guide dermatologists in managing the pandemic response.

背景:冠状病毒病2019(COVID-19)影响不同的器官系统,包括皮肤。目前尚缺乏对中国门诊和住院患者皮肤表现的回顾性分析。本研究旨在分析COVID-19患者的皮肤表现以及既往皮肤病的复发或加重情况:一项回顾性横断面研究于 2022 年 11 月至 2023 年 7 月在华东某大学附属医院进行。研究涉及逆转录酶聚合酶链反应(RT-PCR)阳性的 COVID-19 患者,记录了患者的各种皮肤表现以及既往皮肤病的复发或加重情况。对皮损模式和其他变量进行了评估:研究共纳入 303 名患者,其中男性 127 人,女性 176 人。斑丘疹是最主要的新皮肤表现(54.92%),主要发生在中年人身上。其他表现还包括荨麻疹(16.39%)、带状疱疹(11.89%)、单纯疱疹(4.10%)、水泡疹(2.46%)、紫癜(2.05%)、多形性红斑(1.64%)、网状青斑(0.41%)等。重症病例与带状疱疹和筋膜炎有关。COVID-19 重症病例与水泡性皮疹、紫癜和多形性红斑有关。感染后出现皮损的平均时间从3天(脂溢性皮炎)到17.48天(带状疱疹)不等。血管炎表现与 D-二聚体水平升高有关。感染 COVID-19 后,共有 59 例(19.47%)皮肤病复发或加重,其中皮炎最为常见,其次是痤疮和毛囊炎、银屑病、荨麻疹、大丘疹性类风湿、丘疹性荨麻疹、体癣和雄激素性脱发:本研究中描述的皮肤表型扩大了与 COVID-19 相关的皮肤病范围。皮肤表现可能源于过度活跃的免疫反应、补体激活和微血管损伤。带状疱疹通常发生在免疫系统较弱或疾病较严重的 COVID-19 老年患者身上。紫癜和网状青斑虽然罕见,但可表明疾病的严重程度。通过皮肤表现可以预测不同严重程度的 COVID-19 病程。识别这些皮肤表现有助于预测 COVID-19 的严重程度,并指导皮肤科医生管理大流行反应。
{"title":"Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China.","authors":"Lingyi Lu, Lu Cao, Jing Zhang, Bingjiang Lin","doi":"10.62347/BDUC7952","DOIUrl":"10.62347/BDUC7952","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) affects different organ systems, including the skin. A retrospective analysis of skin manifestations in Chinese outpatient and inpatient settings is lacking. The study aims to analyze cutaneous manifestations in COVID-19 patients and the recurrence or aggravation of previous skin diseases.</p><p><strong>Materials and methods: </strong>A retrospective cross-sectional study was conducted from November 2022 to July 2023 in a university hospital in eastern China. It involved reverse transcriptase polymerase chain reaction (RT-PCR)-positive COVID-19 patients, documenting various skin manifestations and the recurrence or aggravation of pre-existing skin conditions. The pattern of skin lesions and other variables were assessed.</p><p><strong>Results: </strong>The study included 303 patients, with 127 males and 176 females. Maculopapular rash was the predominant new cutaneous manifestation (54.92%), mainly in middle-aged individuals. Other findings included urticaria (16.39%), herpes zoster (11.89%), and herpes simplex (4.10%), vesicular rashes (2.46%), purpura (2.05%), erythema multiforme (1.64%), livedo reticularis (0.41%) and so on. Severe disease was associated with herpes zoster and livedo reticularis. Critical COVID-19 cases were linked to vesicular rashes, purpura, and erythema multiforme. The mean time for skin lesion emergence post-infection varied from 3 days for seborrheic dermatitis to 17.48 days for herpes zoster. Vasculitic manifestations correlated with elevated D-dimer levels. A total of 59 cases (19.47%) of recurrent or aggravated skin diseases were reported following infection with COVID-19, with dermatitis being the most common, followed by acne and folliculitis, psoriasis, urticaria, bullous pemphigoid, pemphigus, tinea corporis and androgenetic alopecia.</p><p><strong>Conclusion: </strong>The cutaneous phenotypes delineated in this study expand the dermatologic spectrum associated with COVID-19. Cutaneous manifestations may result from overactive immune responses, complement activation, and microvascular damage. Herpes zoster typically occurs in elderly COVID-19 patients with weaker immune systems or more severe diseases. Purpura and livedo reticularis, although rare, may indicate disease severity. It is possible to predict the course of COVID-19 with different severity through cutaneous manifestations. Recognizing these skin manifestations could aid in predicting COVID-19 severity and guide dermatologists in managing the pandemic response.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"117-132"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of immune cells and risk factors related to lower limb deep vein thrombosis in patients with cerebral infarction. 脑梗塞患者下肢深静脉血栓形成的免疫细胞及相关风险因素分析。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/DRPN1199
Feng-Dan Hu, Yun Miao, Bo Yu, Xiao-Zhen Deng, Ran Sun, Jin Qian, Hai-Xin Yuan

To explore the characteristics of hematologic indicators and related risk factors of lower extremity deep vein thrombosis (LDVT) in patients with cerebral infarction.

Methods: This study retrospectively analyzed data from 174 patients with cerebral infarction admitted to The Rehabilitation Department of Shanghai Fifth Rehabilitation Hospital and Shanghai First People's Hospital from June 2022 to June 2023. Based on the results of lower limb venous color Doppler ultrasound examinations, patients were divided into two groups: the LDVT group (35 cases) and the non-LDVT group (139 cases). We compared the clinical data and hematologic indicators (D-dimer value, fibrinogen, white blood cells, platelets, uric acid, creatinine, etc.) of the two groups to identify the risk factors of cerebral infarction complicated with LDVT.

Results: Statistical analysis revealed that the D-dimer values of the LDVT group were significantly (P<0.05) higher than those of the non-LDVT group. The uric acid value of the LDVT group was significantly lower than that of the non-LDVT group, with statistical significance (P<0.05). The Brunnstrom staging in the LDVT group was significantly different from that in the non-LDVT group (P<0.05). Meanwhile, binary logistic regression analysis showed that LDVT complicated with cerebral infarction was associated with D-dimer level [OR=1.302, 95% CI (1.077, 1.575)], uric acid level [OR=0.995, 95% CI (0.990, 1.000)], and Brunnstrom staging [OR=3.005, 95% CI (1.312, 6.880)].

Conclusion: D-dimer value, uric acid value, and Brunnstrom stage I to II are closely related to the occurrence of LDVT in patients with cerebral infarction. High D-dimer value, low uric acid value, and Brunnstrom stage I to II are independent risk factors for LDVT in cerebral infarction. Early assessment of D-dimer value, uric acid value, and Brunnstrom stage of cerebral infarction should be considered in clinical practice.

摘要】 目的 探讨脑梗死患者下肢深静脉血栓形成(LDVT)的血液学指标特点及相关危险因素:本研究回顾性分析了2022年6月至2023年6月期间上海市第五康复医院康复科和上海市第一人民医院收治的174例脑梗死患者的资料。根据下肢静脉彩色多普勒超声检查结果,将患者分为两组:LDVT组(35例)和非LDVT组(139例)。我们比较了两组患者的临床资料和血液学指标(D-二聚体值、纤维蛋白原、白细胞、血小板、尿酸、肌酐等),以确定LDVT并发脑梗死的危险因素:统计分析表明,LDVT 组的 D-二聚体值显著(PConclusion:D-二聚体值、尿酸值、BrunnstromⅠ~Ⅱ期与脑梗死患者LDVT的发生密切相关。高 D-二聚体值、低尿酸值和 Brunnstrom I 至 II 期是脑梗死 LDVT 的独立危险因素。临床实践中应考虑对脑梗死的 D-二聚体值、尿酸值和 Brunnstrom 分期进行早期评估。
{"title":"Analysis of immune cells and risk factors related to lower limb deep vein thrombosis in patients with cerebral infarction.","authors":"Feng-Dan Hu, Yun Miao, Bo Yu, Xiao-Zhen Deng, Ran Sun, Jin Qian, Hai-Xin Yuan","doi":"10.62347/DRPN1199","DOIUrl":"10.62347/DRPN1199","url":null,"abstract":"<p><p>To explore the characteristics of hematologic indicators and related risk factors of lower extremity deep vein thrombosis (LDVT) in patients with cerebral infarction.</p><p><strong>Methods: </strong>This study retrospectively analyzed data from 174 patients with cerebral infarction admitted to The Rehabilitation Department of Shanghai Fifth Rehabilitation Hospital and Shanghai First People's Hospital from June 2022 to June 2023. Based on the results of lower limb venous color Doppler ultrasound examinations, patients were divided into two groups: the LDVT group (35 cases) and the non-LDVT group (139 cases). We compared the clinical data and hematologic indicators (D-dimer value, fibrinogen, white blood cells, platelets, uric acid, creatinine, etc.) of the two groups to identify the risk factors of cerebral infarction complicated with LDVT.</p><p><strong>Results: </strong>Statistical analysis revealed that the D-dimer values of the LDVT group were significantly (P<0.05) higher than those of the non-LDVT group. The uric acid value of the LDVT group was significantly lower than that of the non-LDVT group, with statistical significance (P<0.05). The Brunnstrom staging in the LDVT group was significantly different from that in the non-LDVT group (P<0.05). Meanwhile, binary logistic regression analysis showed that LDVT complicated with cerebral infarction was associated with D-dimer level [OR=1.302, 95% CI (1.077, 1.575)], uric acid level [OR=0.995, 95% CI (0.990, 1.000)], and Brunnstrom staging [OR=3.005, 95% CI (1.312, 6.880)].</p><p><strong>Conclusion: </strong>D-dimer value, uric acid value, and Brunnstrom stage I to II are closely related to the occurrence of LDVT in patients with cerebral infarction. High D-dimer value, low uric acid value, and Brunnstrom stage I to II are independent risk factors for LDVT in cerebral infarction. Early assessment of D-dimer value, uric acid value, and Brunnstrom stage of cerebral infarction should be considered in clinical practice.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"133-139"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of LRPPRC and its association with immune infiltration in liver hepatocellular carcinoma. 肝肝细胞癌中 LRPPRC 的预后意义及其与免疫浸润的关系。
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/XTLJ1335
Yanqiu Zhang, Bin Feng, Yuting Liang, Qingqin Tang, Sheng Zhang, Zheng Zhang, Li Xu, Jingping Yin

Background: Leucine rich pentatricopeptide repeat containing (LRPPRC) protein is a multifunctional protein involved in cell cycle progression and tumor development. However, its prognostic significance and association with immune infiltration in Liver hepatocellular carcinoma (LIHC) remain unclear.

Methods: We utilized transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) databases of LIHC patients to investigate the potential pro-cancer role of LRPPRC, including differential expression of LRPPRC in LIHC, prognostic value, clinicopathological features, immune cell infiltration relevance and function enrichment analysis.

Results: Our findings suggest that LRPPRC is upregulated in LIHC and exhibits correlations with survival, clinical stage, and tumor grade in LIHC patients. Additionally, immune infiltration analysis revealed significant negative correlations between LRPPRC expression and multiple tumor-infiltrating immune cells, including CTLs, DCs, pDCs, B cells, Th17 cells, neutrophils, T cells, Mast cells, Th1 cells, Tregs, and NK cells, whereas a significant positive correlation was observed with infiltration of Th2 cells, T helper cells and Tcms. Furthermore, functional enrichment analysis indicated that LRPPRC may be involved in G2m checkpoint, mitotic spindle, E2f targets, Wnt Beta catenin signaling, spermatogenesis and other processes.

背景:富亮氨酸五肽重复蛋白(LRPPRC)是一种参与细胞周期进展和肿瘤发生的多功能蛋白。然而,它在肝肝细胞癌(LIHC)中的预后意义及其与免疫浸润的关系仍不清楚:我们利用癌症基因组图谱(TCGA)和基因型组织表达(GTEx)数据库中LIHC患者的转录组和临床数据研究了LRPPRC的潜在促癌作用,包括LRPPRC在LIHC中的差异表达、预后价值、临床病理特征、免疫细胞浸润相关性和功能富集分析:我们的研究结果表明,LRPPRC在LIHC中上调,并与LIHC患者的生存期、临床分期和肿瘤分级相关。此外,免疫浸润分析表明,LRPPRC 的表达与多种肿瘤浸润免疫细胞(包括 CTLs、DCs、pDCs、B 细胞、Th17 细胞、中性粒细胞、T 细胞、肥大细胞、Th1 细胞、Tregs 和 NK 细胞)呈显著负相关,而与 Th2 细胞、T 辅助细胞和 Tcms 的浸润呈显著正相关。此外,功能富集分析表明,LRPPRC 可能参与了 G2m 检查点、有丝分裂纺锤体、E2f 靶点、Wnt Beta 连环素信号转导、精子发生等过程。
{"title":"Prognostic significance of LRPPRC and its association with immune infiltration in liver hepatocellular carcinoma.","authors":"Yanqiu Zhang, Bin Feng, Yuting Liang, Qingqin Tang, Sheng Zhang, Zheng Zhang, Li Xu, Jingping Yin","doi":"10.62347/XTLJ1335","DOIUrl":"10.62347/XTLJ1335","url":null,"abstract":"<p><strong>Background: </strong>Leucine rich pentatricopeptide repeat containing (LRPPRC) protein is a multifunctional protein involved in cell cycle progression and tumor development. However, its prognostic significance and association with immune infiltration in Liver hepatocellular carcinoma (LIHC) remain unclear.</p><p><strong>Methods: </strong>We utilized transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) databases of LIHC patients to investigate the potential pro-cancer role of LRPPRC, including differential expression of LRPPRC in LIHC, prognostic value, clinicopathological features, immune cell infiltration relevance and function enrichment analysis.</p><p><strong>Results: </strong>Our findings suggest that LRPPRC is upregulated in LIHC and exhibits correlations with survival, clinical stage, and tumor grade in LIHC patients. Additionally, immune infiltration analysis revealed significant negative correlations between LRPPRC expression and multiple tumor-infiltrating immune cells, including CTLs, DCs, pDCs, B cells, Th17 cells, neutrophils, T cells, Mast cells, Th1 cells, Tregs, and NK cells, whereas a significant positive correlation was observed with infiltration of Th2 cells, T helper cells and Tcms. Furthermore, functional enrichment analysis indicated that LRPPRC may be involved in G2m checkpoint, mitotic spindle, E2f targets, Wnt Beta catenin signaling, spermatogenesis and other processes.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"105-116"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of macrophage-related genes in bladder cancer patients using single-cell sequencing and construction of a prognostic model. 利用单细胞测序鉴定膀胱癌患者的巨噬细胞相关基因并构建预后模型
IF 1.4 Q4 IMMUNOLOGY Pub Date : 2024-06-25 eCollection Date: 2024-01-01 DOI: 10.62347/VLDZ7581
Weizhuo Wang, Junheng Shen, Dalong Song, Kai Fu, Xu Fu

Single-cell sequencing is an emerging technology that can effectively identify cell types in tumors. In the tumor microenvironment of bladder cancer, macrophages play a crucial role in invasion and immune escape. This study aimed to assess the expression of macrophage-related genes (MRGs) in the tumor microenvironment of bladder cancer patients and construct a prognostic model based on MRGs using bioinformatics methods.

Methods: Single-cell sequencing data from bladder cancer patients was downloaded from the GEO. After quality control and cell type identification, macrophages in the samples were extracted for re-clustering. Feature genes were then identified, and MRGs were assessed. Genetic data from TCGA database bladder cancer patients was also downloaded and organized. The intersection of MRGs and the TCGA gene set was determined. Clinical information was connected with this intersection, and the data was divided into training and validation sets. The training set was used for model construction and the validation set for model verification. A prognostic model based on MRGs was built using the LASSO algorithm and Cox regression. Patients were divided into high-risk and low-risk groups based on their prognostic features, and survival information in the training and validation sets was observed. The predictive ability of the model was assessed using a ROC curve, followed by a calibration plot to predict 1-, 3-, and 5-year survival rates.

Results: Four cell types were identified, and after extracting macrophages, three cell subgroups were clustered, resulting in 1,078 feature genes. The top 100 feature genes from each macrophage subgroup were extracted and intersected with TCGA expressed genes to construct the model. A risk prediction model composed of CD74, METRN, PTPRR, and CDC42EP5 was obtained. The survival and ROC curves showed that this model had good predictive ability. A calibration curve also demonstrated good prognostic ability for patients.

Conclusion: This study, based on single-cell data, TCGA data, and clinical information, constructed an MRG-based prognostic model for bladder cancer using multi-omics methods. This model has good accuracy and reliability in predicting the survival and prognosis of patients with bladder cancer, providing a reference for understanding the interaction between MRGs and bladder cancer.

单细胞测序是一种新兴技术,能有效识别肿瘤中的细胞类型。在膀胱癌的肿瘤微环境中,巨噬细胞对肿瘤的侵袭和免疫逃逸起着至关重要的作用。本研究旨在评估膀胱癌患者肿瘤微环境中巨噬细胞相关基因(MRGs)的表达情况,并利用生物信息学方法构建基于MRGs的预后模型:方法:从 GEO 下载膀胱癌患者的单细胞测序数据。方法:从 GEO 下载膀胱癌患者的单细胞测序数据,经过质量控制和细胞类型鉴定后,提取样本中的巨噬细胞进行重新聚类。然后确定特征基因,评估MRGs。此外,还从 TCGA 数据库下载并整理了膀胱癌患者的基因数据。确定MRGs与TCGA基因集的交集。临床信息与该交集相连,数据被分为训练集和验证集。训练集用于构建模型,验证集用于验证模型。利用 LASSO 算法和 Cox 回归建立了基于 MRGs 的预后模型。根据预后特征将患者分为高风险组和低风险组,并观察训练集和验证集的生存信息。使用 ROC 曲线评估了模型的预测能力,随后使用校准图预测了 1 年、3 年和 5 年的生存率:结果:确定了四种细胞类型,提取巨噬细胞后,对三个细胞亚群进行了聚类,得出了 1,078 个特征基因。从每个巨噬细胞亚群中提取前100个特征基因,并与TCGA表达基因交叉构建模型。得到了一个由CD74、METRN、PTPRR和CDC42EP5组成的风险预测模型。生存曲线和 ROC 曲线显示,该模型具有良好的预测能力。校准曲线也证明了该模型对患者具有良好的预后能力:本研究基于单细胞数据、TCGA 数据和临床信息,利用多组学方法构建了基于 MRG 的膀胱癌预后模型。该模型在预测膀胱癌患者的生存期和预后方面具有良好的准确性和可靠性,为了解MRGs与膀胱癌之间的相互作用提供了参考。
{"title":"Identification of macrophage-related genes in bladder cancer patients using single-cell sequencing and construction of a prognostic model.","authors":"Weizhuo Wang, Junheng Shen, Dalong Song, Kai Fu, Xu Fu","doi":"10.62347/VLDZ7581","DOIUrl":"10.62347/VLDZ7581","url":null,"abstract":"<p><p>Single-cell sequencing is an emerging technology that can effectively identify cell types in tumors. In the tumor microenvironment of bladder cancer, macrophages play a crucial role in invasion and immune escape. This study aimed to assess the expression of macrophage-related genes (MRGs) in the tumor microenvironment of bladder cancer patients and construct a prognostic model based on MRGs using bioinformatics methods.</p><p><strong>Methods: </strong>Single-cell sequencing data from bladder cancer patients was downloaded from the GEO. After quality control and cell type identification, macrophages in the samples were extracted for re-clustering. Feature genes were then identified, and MRGs were assessed. Genetic data from TCGA database bladder cancer patients was also downloaded and organized. The intersection of MRGs and the TCGA gene set was determined. Clinical information was connected with this intersection, and the data was divided into training and validation sets. The training set was used for model construction and the validation set for model verification. A prognostic model based on MRGs was built using the LASSO algorithm and Cox regression. Patients were divided into high-risk and low-risk groups based on their prognostic features, and survival information in the training and validation sets was observed. The predictive ability of the model was assessed using a ROC curve, followed by a calibration plot to predict 1-, 3-, and 5-year survival rates.</p><p><strong>Results: </strong>Four cell types were identified, and after extracting macrophages, three cell subgroups were clustered, resulting in 1,078 feature genes. The top 100 feature genes from each macrophage subgroup were extracted and intersected with TCGA expressed genes to construct the model. A risk prediction model composed of CD74, METRN, PTPRR, and CDC42EP5 was obtained. The survival and ROC curves showed that this model had good predictive ability. A calibration curve also demonstrated good prognostic ability for patients.</p><p><strong>Conclusion: </strong>This study, based on single-cell data, TCGA data, and clinical information, constructed an MRG-based prognostic model for bladder cancer using multi-omics methods. This model has good accuracy and reliability in predicting the survival and prognosis of patients with bladder cancer, providing a reference for understanding the interaction between MRGs and bladder cancer.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"13 3","pages":"88-104"},"PeriodicalIF":1.4,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of clinical and experimental immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1